In the immune cycle activity scores of LUAD, CHRDL1 is significantly positively correlated with Step2 cancer antigen presentation (cor = 0.472, p < 0.05) and Step4 CD4 T cell recruitment (cor = 0.435, p < 0.05) (Figure 6C; Supplementary Table S4). This evidence concerns the gene CHRDL1 and cancer.